An endocannabinoid-regulated basolateral amygdala-nucleus accumbens circuit modulates sociability

Deficits in social interaction (SI) are a core symptom of autism spectrum disorders (ASDs); however, treatments for social deficits are notably lacking. Elucidating brain circuits and neuromodulatory signaling systems that regulate sociability could facilitate a deeper understanding of ASD pathophysiology and reveal novel treatments for ASDs. Here we found that in vivo optogenetic activation of the basolateral amygdala-nucleus accumbens (BLA-NAc) glutamatergic circuit reduced SI and increased social avoidance in mice. Furthermore, we found that 2-arachidonoylglycerol (2-AG) endocannabinoid signaling reduced BLA-NAc glutamatergic activity and that pharmacological 2-AG augmentation via administration of JZL184, a monoacylglycerol lipase inhibitor, blocked SI deficits associated with in vivo BLA-NAc stimulation. Additionally, optogenetic inhibition of the BLA-NAc circuit markedly increased SI in the Shank3B-/- mouse, an ASD model with substantial SI impairment, without affecting SI in WT mice. Finally, we demonstrated that JZL184 delivered systemically or directly to the NAc also normalized SI deficits in Shank3B-/- mice, while ex vivo JZL184 application corrected aberrant NAc excitatory and inhibitory neurotransmission and reduced BLA-NAc-elicited feed-forward inhibition of NAc neurons in Shank3B-/- mice. These data reveal circuit-level and neuromodulatory mechanisms regulating social function relevant to ASDs and suggest 2-AG augmentation could reduce social deficits via modulation of excitatory and inhibitory neurotransmission in the NAc.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:130

Enthalten in:

The Journal of clinical investigation - 130(2020), 4 vom: 01. Apr., Seite 1728-1742

Sprache:

Englisch

Beteiligte Personen:

Folkes, Oakleigh M [VerfasserIn]
Báldi, Rita [VerfasserIn]
Kondev, Veronika [VerfasserIn]
Marcus, David J [VerfasserIn]
Hartley, Nolan D [VerfasserIn]
Turner, Brandon D [VerfasserIn]
Ayers, Jade K [VerfasserIn]
Baechle, Jordan J [VerfasserIn]
Misra, Maya P [VerfasserIn]
Altemus, Megan [VerfasserIn]
Grueter, Carrie A [VerfasserIn]
Grueter, Brad A [VerfasserIn]
Patel, Sachin [VerfasserIn]

Links:

Volltext

Themen:

Endocannabinoids
Journal Article
Microfilament Proteins
Nerve Tissue Proteins
Neuroscience
Psychiatric diseases
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Shank3 protein, mouse

Anmerkungen:

Date Completed 30.12.2020

Date Revised 29.03.2021

published: Print

Citation Status MEDLINE

doi:

10.1172/JCI131752

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM304742708